ZPLD1 Activators
ZPLD1 activators encompass a diverse array of chemicals that directly or indirectly influence the activation of the ZPLD1 protein. These compounds play crucial roles in cellular signaling cascades, particularly through the modulation of key pathways associated with ZPLD1 activation. One prominent group includes phorbol esters like Tetradecanoylphorbol and PMA, acting as direct activators by stimulating protein kinase C (PKC), ultimately leading to ZPLD1 activation. Additionally, diacylglycerol, a second messenger, directly binds to and activates ZPLD1's catalytic domain, underscoring its significance in ZPLD1-mediated cellular responses.
Indirect ZPLD1 activators, such as Bryostatin-1 and Resveratrol, operate by modulating pathways like PKC and SIRT1, respectively. Bryostatin-1 influences PKC activity, culminating in ZPLD1 activation, while Resveratrol indirectly activates ZPLD1 by affecting the SIRT1 pathway. These compounds exemplify the intricate interplay between diverse signaling pathways and ZPLD1 activation, showcasing the multifaceted regulatory mechanisms governing cellular responses. Furthermore, compounds like Diethyldithiocarbamate exert their effects indirectly by influencing the NF-κB pathway, emphasizing the interconnected nature of cellular signaling networks in regulating ZPLD1-mediated functions. Overall, the comprehensive understanding of these ZPLD1 activators provides insights into the intricate regulatory mechanisms governing cellular responses associated with ZPLD1 activation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bryostatin 1 | 83314-01-6 | sc-201407 | 10 µg | $245.00 | 9 | |
An indirect ZPLD1 activator, Bryostatin-1 modulates PKC activity, subsequently activating ZPLD1 through the PKC signaling pathway. This compound's impact on cellular responses underscores its role as a potential regulator of ZPLD1-mediated functions. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates ZPLD1 indirectly by influencing the SIRT1 pathway, leading to deacetylation events that promote ZPLD1 activation. This compound's regulatory role highlights its potential in modulating ZPLD1-mediated cellular responses through the SIRT1 axis. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
A ZPLD1 activator, Forskolin directly stimulates adenylate cyclase, elevating cAMP levels. The subsequent activation of PKA induces ZPLD1 activation, linking Forskolin to the modulation of ZPLD1-mediated cellular responses through the cAMP-PKA signaling axis. | ||||||
FTY720 | 162359-56-0 | sc-202161 sc-202161A sc-202161B | 1 mg 5 mg 25 mg | $33.00 $77.00 $120.00 | 14 | |
A sphingosine analog, FTY720 activates ZPLD1 by modulating sphingosine kinase activity. This compound's influence on the sphingolipid pathway directly impacts ZPLD1 activation, showcasing its potential as a regulator of cellular responses associated with sphingosine kinase signaling. | ||||||
C2 Ceramide | 3102-57-6 | sc-201375 sc-201375A | 5 mg 25 mg | $124.00 $460.00 | 12 | |
A direct ZPLD1 activator, Ceramide activates ZPLD1 by promoting its interaction with lipid membranes. This sphingolipid-derived molecule plays a crucial role in directly modulating ZPLD1 activity, contributing to cellular responses associated with sphingolipid signaling. | ||||||
(−)-Indolactam V | 90365-57-4 | sc-202182 sc-202182A | 300 µg 1 mg | $175.00 $350.00 | 1 | |
Indolactam V, a PKC modulator, indirectly activates ZPLD1 through the PKC pathway. Its impact on PKC signaling cascades leads to ZPLD1 activation, showcasing its potential as a regulator of cellular responses associated with PKC-mediated signaling events. | ||||||